China Resources Dong-E-E-Jiao Company Limited provided earnings guidance for the three months ended 31 March 2024. On 11 April 2024, Dong-E-E-Jiao released its results estimate for the three months ended 31 March 2024, in which, it announced that the net profit attributable to the shareholders of Dong-E-E-Jiao for the three months ended 31 March 2024 is estimated to range from approximately RMB 334 million to RMB 357 million (as compared to the same period last year of approximately RMB 230.3355 million), net profit excluding non-recurring gain or loss is estimated to range from approximately RMB 309 million to RMB 332 million (as compared to the same period last year of approximately RMB 212.3044 million), and basic earnings per share is estimated to range from approximately RMB 0.52 per share to approximately RMB 0.55 per share (as compared to the same period last year of approximately RMB 0.3577 per share) (the "Dong-E-E-Jiao Results Estimate").
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.78 HKD | -0.17% | -2.69% | +12.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.67% | 4.65B | |
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B |
- Stock Market
- Equities
- 3320 Stock
- News China Resources Pharmaceutical Group Limited
- China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024